Znanstveni rad - Izvorni znanstveni rad
Differences in Outcomes Between Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer Patients in Upper Middle-Income versus High-Income Countries: A Retrospective Study from 4 Oncology Centers
Medical Science Monitor, 29 (2023); e940356. https://doi.org/10.12659/MSM.940356

Miletić, Dragana; Kraljević, Marija; Sokolović, Emir; Soče, Majana; Milović-Kovačević, Marijana; Bobić, Simonida; Cerić, Timur; Pleština, Stjepko; Bešlija, Semir; Marijanović, Inga

Citirajte ovaj rad

Miletić, D., Kraljević, M., Sokolović, E., Soče, M., Milović Kovačević, M., Bobić, S. ... Marijanović, I. (2023). Differences in Outcomes Between Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer Patients in Upper Middle-Income versus High-Income Countries: A Retrospective Study from 4 Oncology Centers. Medical Science Monitor, 29.. doi: 10.12659/MSM.940356

Miletić, Dragana, et al. "Differences in Outcomes Between Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer Patients in Upper Middle-Income versus High-Income Countries: A Retrospective Study from 4 Oncology Centers." Medical Science Monitor, vol. 29, 2023. https://doi.org/10.12659/MSM.940356

Miletić, Dragana, Marija Kraljević, Emir Sokolović, Majana Soče, Marijana Milović Kovačević, Simonida Bobić, Timur Cerić, Stjepko Pleština, Semir Bešlija i Inga Marijanović. "Differences in Outcomes Between Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer Patients in Upper Middle-Income versus High-Income Countries: A Retrospective Study from 4 Oncology Centers." Medical Science Monitor 29 (2023). https://doi.org/10.12659/MSM.940356

Miletić, D., et al. (2023) 'Differences in Outcomes Between Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer Patients in Upper Middle-Income versus High-Income Countries: A Retrospective Study from 4 Oncology Centers', Medical Science Monitor, 29. doi: 10.12659/MSM.940356

Miletić D, Kraljević M, Sokolović E, Soče M, Milović Kovačević M, Bobić S, i sur.. Differences in Outcomes Between Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer Patients in Upper Middle-Income versus High-Income Countries: A Retrospective Study from 4 Oncology Centers. Medical Science Monitor [Internet]. 17.05.2023. [pristupljeno 14.07.2024.];29. doi: 10.12659/MSM.940356

D. Miletić, et al., "Differences in Outcomes Between Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer Patients in Upper Middle-Income versus High-Income Countries: A Retrospective Study from 4 Oncology Centers", Medical Science Monitor, vol. 29, Svibanj 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:134002. [Citirano: 14.07.2024.]